Patients with type 2 diabetes (T2D) at an elevated risk for kidney failure may stand to gain the most renal benefit with intensive glycemic control, but they also face the highest overall risk for ...

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

Please provide your email address to receive an email when new articles are posted on . Tivozanib induced a significantly higher disease control rate than sorafenib among patients with relapsed or ...

Please provide your email address to receive an email when new articles are posted on . Using intensive blood pressure control in patients with stages 4 to 5 chronic kidney disease may delay the onset ...

The BigpAK-2 randomized prospective multicenter trial tested implementation of a bundle of measures to prevent acute kidney injury in high-risk patients undergoing major surgery. Trial results support ...

Over 100 million Americans currently live with high blood pressure, yet many remain unaware of its profound connection to kidney health. This relationship represents one of medicine’s most critical ...

A new meta-analysis further supports the previously reported link between kidney stones and an increased risk for kidney ...